Protext Mobility

Protext Mobility Current Assets

Current Assets of Protext Mobility (TXTM) as of Oct 21, 2026.

Current Assets

0.00USD

Last updated:

Current Assets of Protext Mobility is 2025 0.00 USD. Current Assets of Protext Mobility was 2024 0.00 USD. It decreases by % lower compared to the previous year.

The Protext Mobility Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
0.00 USD
Jan 1, 2019
0.00 USD
Jan 1, 2020
0.00 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
15.00 M USD
Jan 1, 2023
15.00 M USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
The Protext Mobility Current Assets history
YEARCurrent AssetsYoY
0.00USD—
0.00USD-100.00%
15.00 MUSD-0.00%
15.00 MUSD—
0.00USD—
0.00USD—
0.00USD—
0.00USD-100.00%
564.00USD—
0.00USD—
0.00USD-100.00%
4,541.00USD+1,201.15%
349.00USD-96.10%
8,953.00USD-87.62%
72,339.00USD+42.51%
50,761.00USD+10.60%
45,897.00USD-86.83%
348,378.00USD+3.08%
337,969.00USD+43.44%
235,625.00USD+508.19%
38,742.00USD-85.78%
272,398.00USD+5,689.54%
4,705.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Protext Mobility Stock analysis

What does Protext Mobility do? ProText Mobility, Inc. develops pharmaceutical applications for botanical drugs using proprietary live plant extraction technology. The company focuses on research, testing, and development of highly bioavailable botanical products with all-natural ingredients for nutraceutical and pharmaceutical applications. Its subsidiaries include Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc., which support its product development and market reach. The company generates revenue through the sale of pharmaceutical applications and botanical products developed via its proprietary technology. These products target nutraceutical and pharmaceutical markets, with subsidiaries operating in South Africa and cannabis-related research. The primary buyers are companies in the nutraceutical and pharmaceutical sectors seeking natural, highly bioavailable formulations. Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc. contribute to the company's revenue streams by expanding its product portfolio and market presence. The firm's focus on all-natural ingredients and proprietary extraction methods differentiates its offerings in the nutraceutical and pharmaceutical industries. Protext Mobility is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Protext Mobility stock

On Eulerpool you can find the complete historical development of Current Assets Protext Mobility since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Protext Mobility historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Protext Mobility

All Key Metrics — Protext Mobility